2.30
price down icon7.63%   -0.19
after-market Handel nachbörslich: 2.30
loading

Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
37.13%
0.0193
0.0307 0.0645 0.0313
Operating Expenses
3.34%
3.24
3.1351 3.1811 5.8104
Benefits Costs and Expenses
-
- - -
Costs And Expenses
3.34%
3.24
3.1351 3.1811 5.8104
Provision For Loan, Lease, And Other Losses
-
- - -
Depreciation and Amortization
0.0427
- - -
Operating Income/Loss
3.74%
-3.2207
-3.1044 -3.1166 -5.7791
Net Interest Income/Expense
510.09%
0.3762
0.0617 0.0962 0.0182
Nonoperating Income/Loss
120.99%
0.3955
0.179 0.136 0.0949
Income/Loss From Continuing Operations Before Tax
37.13%
0.0193
0.0307 -2.9806 -5.6842
Income/Loss From Continuing Operations After Tax
3.43%
-2.8252
-2.9255 -2.9806 -5.6842
Net Income/Loss
3.43%
-2.8252
-2.9255 -2.9806 -5.6842
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
96.58%
0.1564
4.5708 3.8863 3.7175
Diluted Average Shares
96.58%
0.1564
4.5708 3.8863 -0.083
Basic Earnings Per Share
10.94%
-0.57
-0.64 -0.77 -1.53
Diluted Earnings Per Share
10.94%
-0.57
-0.64 -0.77 -1.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Kapitalisierung:     |  Volumen (24h):